Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibitionYoko Katsuno, Rik Derynck, Kohei Miyazono et al.|Science Signaling|2019Cited by 229